Cargando…

The Future of Telehealth for Allergic Disease

The COVID-19 pandemic created an explosion in the use of telehealth. However, telehealth consists of much more than a video discussion between doctor and patient. Since the onset of the COVID-19 pandemic, allergists have demonstrated a high level of synchronous telemedicine adoption with existing pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Bajowala, Sakina S., Shih, Jennifer, Varshney, Pooja, Elliott, Tania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420069/
https://www.ncbi.nlm.nih.gov/pubmed/36038132
http://dx.doi.org/10.1016/j.jaip.2022.08.022
_version_ 1784777310895865856
author Bajowala, Sakina S.
Shih, Jennifer
Varshney, Pooja
Elliott, Tania
author_facet Bajowala, Sakina S.
Shih, Jennifer
Varshney, Pooja
Elliott, Tania
author_sort Bajowala, Sakina S.
collection PubMed
description The COVID-19 pandemic created an explosion in the use of telehealth. However, telehealth consists of much more than a video discussion between doctor and patient. Since the onset of the COVID-19 pandemic, allergists have demonstrated a high level of synchronous telemedicine adoption with existing patients but have not taken full advantage of other virtual care modalities that have the potential to facilitate the efficient delivery of allergy care to the broader population. This is partially due to a lack of awareness about the various remote care services and how to implement and bill for them appropriately. This rostrum describes the spectrum of telehealth services, reviews existing literature on the use of telehealth in allergy, and provides suggestions about how allergists and immunologists can optimize the use of telehealth to optimize patient access and outcomes as well as receive appropriate compensation for specialty clinical services provided by themselves and their staff.
format Online
Article
Text
id pubmed-9420069
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Academy of Allergy, Asthma & Immunology
record_format MEDLINE/PubMed
spelling pubmed-94200692022-08-30 The Future of Telehealth for Allergic Disease Bajowala, Sakina S. Shih, Jennifer Varshney, Pooja Elliott, Tania J Allergy Clin Immunol Pract Review and Feature Article The COVID-19 pandemic created an explosion in the use of telehealth. However, telehealth consists of much more than a video discussion between doctor and patient. Since the onset of the COVID-19 pandemic, allergists have demonstrated a high level of synchronous telemedicine adoption with existing patients but have not taken full advantage of other virtual care modalities that have the potential to facilitate the efficient delivery of allergy care to the broader population. This is partially due to a lack of awareness about the various remote care services and how to implement and bill for them appropriately. This rostrum describes the spectrum of telehealth services, reviews existing literature on the use of telehealth in allergy, and provides suggestions about how allergists and immunologists can optimize the use of telehealth to optimize patient access and outcomes as well as receive appropriate compensation for specialty clinical services provided by themselves and their staff. American Academy of Allergy, Asthma & Immunology 2022-10 2022-08-28 /pmc/articles/PMC9420069/ /pubmed/36038132 http://dx.doi.org/10.1016/j.jaip.2022.08.022 Text en © 2022 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review and Feature Article
Bajowala, Sakina S.
Shih, Jennifer
Varshney, Pooja
Elliott, Tania
The Future of Telehealth for Allergic Disease
title The Future of Telehealth for Allergic Disease
title_full The Future of Telehealth for Allergic Disease
title_fullStr The Future of Telehealth for Allergic Disease
title_full_unstemmed The Future of Telehealth for Allergic Disease
title_short The Future of Telehealth for Allergic Disease
title_sort future of telehealth for allergic disease
topic Review and Feature Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420069/
https://www.ncbi.nlm.nih.gov/pubmed/36038132
http://dx.doi.org/10.1016/j.jaip.2022.08.022
work_keys_str_mv AT bajowalasakinas thefutureoftelehealthforallergicdisease
AT shihjennifer thefutureoftelehealthforallergicdisease
AT varshneypooja thefutureoftelehealthforallergicdisease
AT elliotttania thefutureoftelehealthforallergicdisease
AT bajowalasakinas futureoftelehealthforallergicdisease
AT shihjennifer futureoftelehealthforallergicdisease
AT varshneypooja futureoftelehealthforallergicdisease
AT elliotttania futureoftelehealthforallergicdisease